Genmab | GEN - Capitale Di Prestito

Prezzo Delle Azioni
1,690.50
Cambio Giornaliero
6.50 0.39%
Mensile
-4.76%
Annuale
28.07%
Q2 Previsione
1,604.35




Capitale Di Prestito Cambiamento Data
Agios Pharmaceuticals USD 1.06M 0 2022-09
Almirall EUR 324.81M 61.32M 2025-12
Amgen USD 51.89B 1.88B 2026-03
argenx SE USD 35.57M 3.05M 2025-06
AstraZeneca USD 25.96B 177M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Demant DKK 18.98B 3.71B 2025-12
Fresenius Medical Care EUR 5.74B 895.27M 2026-03
Genmab DKK 5.14B 5.01B 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
GN Store Nord DKK 8.1B 790M 2026-03
GRIFOLS EUR 9.08B 612M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Insmed USD 542.22M 1.25M 2026-03
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.8B 72M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
UCB EUR 2.18B 634M 2025-12